Log in to search using one of your social media accounts:


UC regents appoint Dr. Owen Witte University Professor

Dr. Owen Witte, renowned scientist and esteemed member of UCLA’s faculty, has been appointed a University Professor by the University of California Board of Regents. This appointment is reserved for scholars of the highest international distinction, who are respected as teachers of exceptional ability and whose contributions elevate the entire UC system. The University Professor title was established by the regents so that the entire UC system can benefit from the talents of outstanding faculty. Witte joins the ranks of just 40 UC faculty, including several Nobel laureates, who have received this honor since 1960. “Dr. Witte has made a significant impact at UCLA through his scientific achievements and visionary leadership,” said UCLA Chancellor Gene Block. “As University Professor, Witte’s efforts to unite and energize collaborative biomedical research across the UC system will only build upon his legacy — and further strengthen the competitiveness of our research enterprise.”   Witte’s accomplishments include impactful scientific discoveries, advocacy for science education funding and exemplary leadership as founding director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA. His ability to create strategic partnerships across disciplines enables groups of elite clinicians, scientists and engineers to pursue breakthrough research with the shared goal of improving human health. Those...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news

Related Links:

Authors: Sharma P, King GT, Shinde SS, Purev E, Jimeno A Abstract B-cell non-Hodgkin's lymphomas are the most common hematological malignancies, which despite improvements in chemo-immunotherapy, carry a uniformly poor prognosis in the relapsed/refractory setting. CD19 is an antigen expressed on the surface of most malignancies arising from the B cells, and adoptive transfer of anti-CD19 chimeric antigen receptor (CAR)-expressing T cells has been shown to be effective in treating these B-cell malignancies. Axicabtagene ciloleucel (axi-cel, KTE-C19) is an autologous anti-CD19 CAR T-cell therapy which has shown high ...
Source: Drugs of Today - Category: Drugs & Pharmacology Tags: Drugs Today (Barc) Source Type: research
This test is a cheaper and less invasive alternative to an upper endoscopy.
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
CONCLUSIONS We found for the first time that PMEF has a role in stimulating cell proliferation of hASCs at an early period, subsequently promoting bone-related gene expression and inducing the expression of related proteins to stimulate osteogenic differentiation. PMID: 29775452 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
In this study, chitosan was used to coat the adsorbent for preventing the leakage of Zn2+ loaded. Meanwhile, freeze-drying method was used to enhance adsorption capacity of Zn2+-loaded cellulose beads for testosterone. The results indicate that after the adsorbent was coated by 0.02% chitosan solution, the highest adsorption percentage reached 48%, during adsorption, the Zn2+ concentration in plasma did not increase; the adsorption capacity of the adsorbent can be significantly enhanced by freeze-drying. The results may be caused by porosity of the adsorbent enlarged via freeze-drying and improved stability by coating with...
Source: Artificial Cells, Nanomedicine and Biotechnology - Category: Biotechnology Tags: Artif Cells Nanomed Biotechnol Source Type: research
BOWEL cancer symptoms include stomach pain, a change in bowel habits, and finding blood in your stool. You could reveal your risk of the cancer by checking your poo after using the toilet. Should a healthy poo sink or float?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
CONCLUSIONS: This study shows that direct contact with 1 week post-set MTA significantly decreases the viability of SHEDs and induced cell apoptosis. The results suggest that there is a possible cytotoxic effect of pulp tissue when there is direct contact with MTA. Different responses would be expected due to the strong alkaline characteristics of fresh mixed MTA. PMID: 29764492 [PubMed - in process]
Source: BMC Pharmacology and Toxicology - Category: Drugs & Pharmacology Tags: BMC Pharmacol Toxicol Source Type: research
Conclusions RAPN in the setting of select cT2 renal masses can safely be performed with acceptable outcomes. Further studies are warranted to corroborate our findings and to better define the role of robotic nephron sparing for this challenging indication. Patient summary This report shows that robotic surgery can be used for safe removal of a large renal tumor in a minimally invasive fashion, maximizing preservation of renal function, and without compromising cancer control. This large multicenter experience suggests that robot-assisted partial nephrectomy for clinical T2 renal masses is feasible, it offers good surgical ...
Source: European Urology - Category: Urology & Nephrology Source Type: research
AbstractThe Ontario Breast Screening Program for women with a genetic predisposition to breast cancer is one of the first international models of a government-funded public health service that offers systematic genetic screening to women at a high risk of breast cancer. However, since the implementation of the program in 2011, enrolment rates have been lower than anticipated. Whilst there may be several reasons for this to happen, it does call into consideration the ‘inverse equity law’, whereby the more advantaged in society are the first to participate and benefit from universal health services. An outcome of...
Source: Journal of Community Genetics - Category: Genetics & Stem Cells Source Type: research
Publication date: Available online 19 May 2018 Source:Seminars in Cancer Biology Author(s): George Cyriac, Leena Gandhi Immune checkpoint inhibition with anti-PD-1 therapy has been notably successful in non-small cell lung cancer (NSCLC) and changed standard practice in multiple settings. However, despite some durable benefits seen, the majority of unselected patients with NSCLC fail to respond to checkpoint inhibitors. Patient selection is crucial and will become even more important in the development of combination therapies with immune checkpoint inhibitors. PD-L1 expression by immunohistochemistry (IHC) has emerged as...
Source: Seminars in Cancer Biology - Category: Cancer & Oncology Source Type: research
Publication date: Available online 19 May 2018 Source:Chinese Chemical Letters Author(s): Shasha Ying, Shubo Du, Jia Dong, Bi Xuan Ng, Chengwu Zhang, Lin Li, Jingyan Ge, Qing Zhu Wortmannin, a known inhibitor of phosphoinositide 3-kinases (PI3Ks), their low selectivity and high toxicity is still problematic and less is known about their effects on PI3Ks in cellular systems. Hence, we have synthesized a series of multifunctional wortmannin probes with the ability to self-activate, by installing a clickable handle at C11 site, and secondary amine and cancer-targeting moiety at C20 site, respectively. MTT assay first confirm...
Source: Chinese Chemical Letters - Category: Chemistry Source Type: research
More News: Academia | Biology | Biomedical Science | Cancer | Cancer & Oncology | Cancer Therapy | Child Development | Children | Chronic Leukemia | Chronic Myeloid Leukaemia | Cytology | Education | Funding | Genetics | Gleevec | Graduation | Grants | Harvard | Health | Hospitals | Leukemia | Lymphoma | Partnerships | Pathology | Prostate Cancer | Science | Stem Cell Therapy | Stem Cells | Students | Study | Teachers | Teaching | Training | Transplants | Universities | Universities & Medical Training